IntrinsicIntrinsic
← Scroll for more →

Financial Statements — MED

Balance Sheet

(in millions USD)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Cash & Equivalents58.3771.9171.5389.3099.53101.6991.7290.93115.31108.0297.4794.44112.75147.41123.7587.6969.7161.07118.00104.18
Short-term Investments114.1697.9197.4277.9773.9960.9872.8871.4254.6555.4958.96--------0.000.000.004.065.36
Accounts Receivable----------------------------------------
Inventory21.2021.1821.4020.2323.2130.2039.3642.4240.1039.6046.2754.5958.2368.9096.90118.86145.28156.97188.97180.04
Total Current Assets201.94202.03202.63201.68207.84206.44213.52214.40224.98224.32219.58224.03224.28228.82230.32222.78229.58243.30324.26306.87
Property, Plant & Equipment13.2527.9829.6431.2332.8534.6036.3137.5339.0039.9250.9951.4753.4854.4155.9657.1958.1158.5457.8056.13
Total Non-current Assets*37.8358.3749.4246.2960.3762.8966.4969.8166.2669.2283.1885.8895.7489.9191.2993.4396.7797.2597.1891.46
Total Assets239.76260.40252.05247.97268.21269.33280.01284.21291.24293.53302.76309.91320.02318.73321.61316.21326.35340.55421.44398.33
Accounts Payable38.8036.4138.2638.3641.2440.2651.8256.4966.2769.1571.2386.42103.22105.19113.30134.69148.13154.78174.37163.31
Total Current Liabilities41.8841.5642.1842.9646.7146.1860.6064.1672.3875.1877.1992.30110.11114.90131.74140.89154.26188.16181.03169.83
Total Non-current Liabilities*17.6122.4612.186.096.797.148.459.9411.5213.0714.6116.1316.8718.2718.9620.2721.5722.9124.3826.02
Total Liabilities59.4964.0254.3749.0553.5053.3369.0574.1083.9088.2591.80108.43126.98133.16150.71161.17175.83211.07205.41195.85
Retained Earnings135.54153.05156.15158.27176.24178.49176.01176.78175.98174.85182.97174.65168.78163.89151.83139.85131.50129.20203.05190.33
Total Stockholder Equity180.28196.38197.68198.92214.71216.01210.96210.11207.34205.28210.96201.48193.04185.56170.90155.04150.52129.48216.02202.47
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Total Revenue72.0576.3876.0475.1089.41105.56115.73119.00140.16168.56174.74191.01235.87296.19348.98337.25390.40453.33417.60377.83
Cost of Revenue22.0122.9924.2922.9627.2528.9131.4830.7834.4945.1247.4549.6558.4985.47102.59103.65107.55131.65115.3199.55
Gross Profit50.0453.4051.7652.1462.1676.6484.2588.22105.67123.44127.29141.37177.38210.72246.39233.60282.85321.68302.29278.29
Selling, General & Admin69.4057.7255.0559.9466.2477.7185.5187.51103.57131.31119.35132.69151.87172.01192.88201.00234.69272.72247.20231.45
Total Operating Expenses*69.4057.7255.0559.9466.2477.7185.5187.51103.57131.31192.88132.69151.87519.92192.88201.00234.69272.72247.20231.45
Operating Income(19.36)(4.33)(3.29)(7.80)(4.08)(1.07)(1.26)0.712.11(7.88)7.948.6825.5138.7153.5132.6048.1648.9655.0946.84
Pretax Income(17.83)(2.99)(1.94)(6.38)(2.66)2.880.531.271.58(10.65)11.599.8026.5539.1253.3332.4147.8848.8054.9846.75
Tax Provision(0.32)0.110.1811.74(0.40)0.401.300.470.45(2.50)3.273.773.428.8413.365.8911.729.6813.2012.73
Net Income(17.51)(3.10)(2.12)(18.12)(2.26)2.48(0.77)0.801.13(8.15)8.326.0423.1330.2839.9726.5236.1639.1141.7834.02
Basic EPS(1.57)(0.28)(0.19)(1.65)(0.21)0.23(0.07)0.080.10(0.75)0.760.552.122.783.682.463.303.443.622.93
Diluted EPS(1.57)(0.28)(0.19)(1.64)(0.21)0.22(0.07)0.080.10(0.75)0.760.542.122.773.672.453.273.423.592.91
← Scroll for more columns →

* Derived from reported values

Cash Flow Statement

(in millions USD)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Operating Cash Flow3.301.700.26(5.28)12.11(3.38)3.41(4.95)9.0713.077.2810.5229.9343.1564.0651.7455.4043.7643.67(7.46)
Capital Expenditures0.430.971.101.351.361.381.522.291.391.941.840.951.681.742.129.061.772.843.0111.62
Free Cash Flow*2.870.73(0.84)(6.63)10.75(4.76)1.88(7.23)7.6811.135.449.5828.2541.4061.9442.6853.6340.9240.66(19.08)
Investing Cash Flow(16.82)(1.23)(17.13)(4.95)(14.28)13.36(2.05)(19.43)(1.78)(2.53)(2.77)(10.73)(46.46)(1.74)(2.12)(9.06)(1.77)1.18(1.76)(11.62)
Financing Cash Flow(0.01)(0.08)(0.90)0.000.00-0.00(0.56)-0.00-0.00(0.02)(1.49)(17.90)(18.15)(17.83)(25.90)(24.33)(45.11)(102.02)(28.12)(31.23)
← Scroll for more columns →

* Derived from reported values

Dividends Per Share

(USD)
MetricQ4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020Q2 2020Q1 2020
Dividends Per Share0.000.000.000.000.001.651.651.651.641.641.641.641.421.421.421.421.131.131.131.13
← Scroll for more columns →